David Matthews trained at the University of Oxford (BA, BM, BCh, MA and DPhil). He is a Fellow of the Royal College of Physicians (FRCP) and Hon DM (honoris causa) of Aristotle University, Thessaloniki.

Professor Matthews has devoted his life to diabetes – combining clinical care, teaching and research. His studies have focused on type 2 diabetes, including insulin secretion and action, insulin resistance, mathematical modelling of insulin resistance and the analysis of pulsatile insulin (and other hormones, especially growth hormone) using time-series analysis. He has been part of, and led, many trials in diabetes.

As well as having given many lectures worldwide, his medical teaching and assessment experience includes organising and running the MRCP Part 1 course at Central Middlesex Hospital and lectures on diabetes at the Oxford Medical School. He was Director of Medical Studies at Harris Manchester College (1996-2008) and instituted and directed the Robert Turner Post-graduate course (residential) at Oxford until 2019.

He was deputy co-ordinator and member of the Executive and Policy Advisory Committees of the UK Prospective Study of Diabetes (UKPDS) and founder member of the Oxford Health Alliance, a multiple stakeholder collaboration to address and prevent chronic illness. He was a Senior Investigator with the National Institute of Health Research (NIHR); co-director (2005-2013) of the National Diabetes Research Network (UKDRN), which was managed jointly by Imperial College London and Oxford University. He was chair of the joint EASD and ADA guideline committees (2012 and 2015); co-chair of the CANVAS and CANVAS-R studies; chair of the Steering committee of the VERIFY trial. He is on the steering committee for the FOCUS trial.

He raised the funding for, and oversaw the building of the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), of which he was the first Chairman (1999-2013). Over the course of his career he has authored more than 358 peer-reviewed publications (citations: >100,000 [Nov 2023]; H index: 98). He has also undertaken peer review for many top-ranking journals, including Diabetes, Diabetes Care, Diabetologia and the Lancet, and is on the Editorial Board for Diabetic Medicine. He delivered the 2010 Banting lecture for Diabetes UK, for whom he also served as Chair of the Grants Committee. He is a past President of the EASD.

Duality of Interest: Professor Matthews lectures for Novartis, Merck, Sanofi and Servier and is a steering committee member of FOCUS (Novo Nordisk), payments for this work are less than 5,000 Euros.
Date: Winter 2023